RecruitingNot Applicable

Outcome of GATT Combined With Goniosynechiolysis in Glaucoma Patients With Secondary Synechial Angle Closure.

Egypt23 participantsStarted 2024-04-01

Plain-language summary

To evaluate the intraocular pressure reduction effect of combined gonioscopy-assisted transluminal trabeculotomy (GATT) with goniosynechialysis in eyes with secondary synechial angle closure glaucoma.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with secondary synechial angle closure glaucoma * Involving more than 180 degrees of the iridocorneal angle * Requiring surgery for uncontrolled IOP despite maximum tolerated therapy. Exclusion Criteria: * Eyes with PACG. * Eyes with neovascular glaucoma. (Some apparently stable NVG cases would have remnants of neo-vessels in the angle that are hidden behind the synechiae). * Eyes with retinal pathology. * Eyes requiring combined phacoemulsification and GATT. * Eyes with corneal pathology that can preclude surgery and imaging.

What they're measuring

IOP and glaucoma medications.

Timeframe: 1day,1 week,1 months, 3 months, 6 months and 1 year

Surgical success.

Timeframe: 1day,1 week,1 months, 3 months, 6 months and 1 year

Trial details

NCT IDNCT06445634

SponsorKasr El Aini Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-01

Contact for this trial

Rokaya Radwan

01066471468 rokaia.e.radwan@students.kasralainy.edu.eg

View on ClinicalTrials.gov More Glaucoma, Angle-Closure trials